UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 17, 2012
TRANSBIOTEC, INC.
-----------------
(Exact name of Registrant as specified in its charter)
Delaware 000-53316 26-0731818
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
3030 Old Ranch Parkway, Suite 350
Seal Beach, CA 90740
-------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (562) 280-0483
N/A
------------------------------------------------
(Former name or former address if changed since last report)
Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On May 17, 2012 Charles Bennington resigned as the Company's Chief
Executive Officer and was appointed the Company's Chief Operating Officer. On
the same day Scott Painter was appointed the Company's Chief Executive Officer
and a director.
Scott Painter (age 64) has been an independent investment banking
consultant since February 2007. Between December 2006 and February 2007 Mr.
Painter was the Chief Executive Officer of Straight Shot Communications, a
Company involved in the development of web based communications.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: May 17, 2012
TRANSBIOTEC, INC.
By: /s/ Scott Painter
---------------------------------------
Scott Painter, Chief Executive Officer
3